CRON
Cronos Group Inc. Health Care Medicinal Chemicals & Botanical Products Russell 3000
$3.30Close
$1.3BMarket cap
$2.30 – $3.5552-week range
Nov 5, 2026Next report · before the open
Highlights
Strengths
- Leading the market RS 81 · stronger than 81% of stocks over 12 months
- Tight base near its pivot pullbacks 14% → 9% → 6%; 4.8% below its $3.46 pivot
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
down 1.5%
price change
1mo
0.0%
price change
12-month return
up 35%
market up 11% ·
its own up 23%
F-score
7 / 9
Strong
Altman Z
15.44
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
1.2×
price / book
Earnings yield
down 3.7%
EBIT / enterprise value
Cheaper than
42%
of the market · around average
Revenue growth
up 25%
year on year
EPS growth
—
latest quarter
Sales growth
up 58%
latest quarter · +18 pts
ROE
0%
return on equity
Free cash margin
0%
$149,000 FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- no new shares issued
- gross margin widened
- assets working harder
Repair signals
- Gross margin 21.4% → 42.8%
Trade setup
ATR%
2.8%
$0.09 a day · 2×ATR $3.11
RS
81 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
1.1×
vs 50-day average
Up/down volume
1.20
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Contractions
3
14% → 9% → 6%
Pivot
$3.46
4.8% below
Volume dry-up
0.9×
10 vs 50 sessions
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+14% vs market2 sessions after results
Financials
- Gross 43%
- Net -2%
- Free cash 0%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $46.7M | $64.6M | $86.7M | $87.2M | $117.6M | $146.6M |
| Gross margin | -55% | -27% | 18% | 14% | 21% | 43% |
| Operating income | -$219.4M | -$292.0M | -$111.4M | -$84.8M | -$76.5M | -$17.4M |
| Net income | -$73.1M | -$396.1M | -$168.7M | -$73.9M | $40.0M | -$2.9M |
| Net margin | -157% | -614% | -194% | -85% | 34% | -2% |
| Earnings per share | -$0.21 | -$1.07 | -$0.45 | -$0.19 | $0.10 | -$0.01 |
| Free cash flow | -$176.3M | -$164.8M | -$92.4M | -$45.3M | $6.4M | $149,000 |
| Free cash margin | -377% | -255% | -107% | -52% | 5% | 0% |
| Cash | $1.1B | $887.0M | $764.6M | $669.3M | $858.8M | $791.8M |
| Shareholders' equity | $1.7B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B |
| Shares outstanding | 360.25m | 374.95m | 380.58m | 381.30m | 382.53m | 381.59m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 11, 2026 | Quarterly ↗ | Mar 31, 2026 | 41d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 15, 2026 | Material agreement · Acquisition or disposal · Regulation FD ↗ |
| Sep 11, 2026 | Material agreement ↗ |
| Aug 6, 2026 | Results ↗ |
| Jun 22, 2026 | Shareholder vote ↗ |
| May 11, 2026 | Material agreement · Results · Other events ↗ |
| Feb 26, 2026 | Results ↗ |
| Dec 9, 2025 | Material agreement · Regulation FD ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 29, 2025 | Director or officer change ↗ |
| Aug 7, 2025 | Results · Director or officer change ↗ |
| Jun 24, 2025 | Shareholder vote ↗ |
| May 8, 2025 | Results · Other events ↗ |